RESPeRATE
PrivateLast Round
IPO
Jul 31, 2007
Est. Valuation
$66M
Total Funding Raised
$12.9M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
RESPeRATE operates in Healthcare & Life Sciences and is based in Newark, New Jersey. Its latest recorded funding round was a Series C round in April 2005.
RESPeRATE is a medical device company that provides an FDA-cleared, non-drug device for lowering blood pressure through patented, device-guided breathing technology.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, D2C Brands, Home & Lifestyle
Business Model
B2C
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RESPeRATE Comparables
Compare RESPeRATE with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| HeartMath | 77% | |
| AliveCor | 70% | |
| Lief Therapeutics | 66% |
For institutional investors. Book with your work email.
RESPeRATE Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Jul 31, 2007 | ||||
| Series C | Apr 14, 2005 | ||||
| Series B | Oct 30, 2001 | ||||
| Series A | Jan 5, 2000 |
For institutional investors. Book with your work email.
RESPeRATE Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| I.B.I. - Managing & Underwriting Ltd. | IPO |
| 日本ベンチャーキャピタル株式会社 | Series C |
| Paladin Capital Group | Series B |
| Palladin Consumer Retail Partners | IPO |
| Ant Capital Partners | Series C |
| Medica Venture Partners | IPO, Series C, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 63% MoM.
- May 19, 2026
Monthly visitors grew 39% MoM, reaching 39.8K.
For institutional investors. Book with your work email.
RESPeRATE Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about RESPeRATE's valuation, stock price, and market status.
Is RESPeRATE a public or private company?
RESPeRATE is a private company.
What is the current stock price of RESPeRATE?
RESPeRATE is a private company, so its shares have no public market price. Caplight tracks RESPeRATE's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is RESPeRATE worth (valuation)?
RESPeRATE's valuation is estimated at $66.0M based on funding round data.
Can I buy RESPeRATE stock?
RESPeRATE shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was RESPeRATE's last funding round?
RESPeRATE's most recent funding round was IPO on July 31, 2007.
Who are the main investors in RESPeRATE?
Key investors in RESPeRATE include I.B.I. - Managing & Underwriting Ltd., 日本ベンチャーキャピタル株式会社, Ant Capital Partners, Medica Venture Partners.
Will RESPeRATE IPO soon?
No public IPO plans have been announced for RESPeRATE.
How can I track RESPeRATE secondary market activity?
Caplight tracks bids, offers, and trades in RESPeRATE's shares on secondary markets.